TCM Past Earnings Performance
Past criteria checks 0/6
TCM's earnings have been declining at an average annual rate of -44%, while the Chemicals industry saw earnings growing at 15.2% annually. Revenues have been growing at an average rate of 66.3% per year.
Key information
-44.0%
Earnings growth rate
-33.2%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | 66.3% |
| Return on equity | -9.4% |
| Net Margin | -7.5% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How TCM makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 302 | -23 | 39 | 0 |
| 31 Mar 24 | 322 | -20 | 60 | 0 |
| 31 Dec 23 | 286 | -26 | 30 | 0 |
| 30 Sep 23 | 180 | -46 | 31 | 0 |
| 30 Jun 23 | 140 | -36 | 23 | 0 |
| 31 Mar 23 | 73 | -40 | 22 | 0 |
| 31 Dec 22 | 38 | -54 | 18 | 0 |
| 30 Sep 22 | 27 | -50 | 14 | 0 |
| 30 Jun 22 | 31 | -42 | 17 | 0 |
| 31 Mar 22 | 36 | -51 | 22 | 0 |
| 31 Dec 21 | 50 | -16 | 28 | 0 |
| 30 Sep 21 | 61 | 1 | 27 | 0 |
| 30 Jun 21 | 53 | 1 | 13 | 0 |
| 31 Mar 21 | 43 | 1 | 11 | 0 |
| 31 Dec 20 | 15 | 8 | 9 | 0 |
| 30 Sep 20 | 6 | 1 | 6 | 0 |
| 30 Jun 20 | 8 | 3 | 4 | 0 |
| 31 Mar 20 | 9 | 3 | 4 | 0 |
| 31 Dec 19 | 9 | -5 | 4 | 0 |
| 30 Sep 19 | 7 | -6 | 4 | 0 |
| 30 Jun 19 | 4 | -7 | 3 | 0 |
| 31 Mar 19 | 4 | -9 | 3 | 0 |
| 31 Dec 18 | 4 | -10 | 2 | 0 |
| 30 Sep 18 | 2 | -10 | 1 | 0 |
| 30 Jun 18 | 2 | -10 | 1 | 0 |
| 31 Mar 18 | 0 | -7 | 1 | 0 |
| 31 Dec 17 | 0 | -4 | 1 | 0 |
| 30 Sep 17 | 0 | -5 | 1 | 0 |
| 30 Jun 17 | 0 | -7 | 0 | 0 |
| 31 Mar 17 | 0 | -6 | 1 | 0 |
| 31 Dec 16 | 0 | -7 | 0 | 0 |
| 30 Sep 16 | 0 | -7 | 1 | 0 |
| 30 Jun 16 | 0 | -6 | 0 | 0 |
| 31 Mar 16 | 0 | -5 | 1 | 0 |
| 31 Dec 15 | 0 | -5 | 2 | 0 |
| 30 Sep 15 | 0 | -5 | 2 | 0 |
| 30 Jun 15 | 0 | -4 | 2 | 0 |
| 31 Mar 15 | 0 | -5 | 1 | 0 |
| 31 Dec 14 | 0 | -14 | 10 | 0 |
| 30 Sep 14 | 0 | -15 | 11 | 0 |
| 30 Jun 14 | 0 | -14 | 11 | 0 |
| 31 Mar 14 | 0 | -14 | 11 | 0 |
| 31 Dec 13 | 0 | -24 | 9 | 0 |
Quality Earnings: 524156 is currently unprofitable.
Growing Profit Margin: 524156 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 524156 is unprofitable, and losses have increased over the past 5 years at a rate of 44% per year.
Accelerating Growth: Unable to compare 524156's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 524156 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (10.9%).
Return on Equity
High ROE: 524156 has a negative Return on Equity (-9.39%), as it is currently unprofitable.